Janux Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Dobek Maria
Janux Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Advisors LLC(3.8%),OrbiMed Capital GP VIII LLC(3.4%), etc.
Janux Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director DOBMEIER ERIC
Janux Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Hernday Natasha
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director DOBMEIER ERIC
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hernday Natasha
Janux Therapeutics | 3: Initial statement of beneficial ownership of securities-Director DOBMEIER ERIC
Janux Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Hernday Natasha
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director CAPPS VICKIE L
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Simson Jake
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Barrett Ronald W
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gujrathi Sheila
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kung Winston
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director McNulty Alana B.
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lichter Jay
Janux Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jay Lichter, Ph.D.(14.1%),Tighe Reardon(8.5%), etc.
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lichter Jay
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Reardon Tighe
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Avalon Ventures XI, L.P.
No Data